{"nct_id":"NCT02559687","title":"Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)","status":"COMPLETED","status_verified_date":"2022-08","start_date":"2015-12-02","start_date_type":"ACTUAL","primary_completion_date":"2018-07-30","primary_completion_date_type":"ACTUAL","completion_date":"2021-10-29","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}